Vestagen develops and markets advanced performance textile products and technologies including Vestex®, the first in a new class of medical devices based on active barrier protective fabrics that are clinically proven to prevent or reduce the acquisition and retention of contaminants on clothing. Vestex garments are engineered to have robust liquid repellency and antimicrobial properties, along with breathability, comfort and durability. Based in Orlando, FL, Vestagen is led by CEO Ben Favret and a tenured team comprised of healthcare, biopharmaceutical, consumer products, apparel, textile manufacturing and regulatory experts. The team has extensive experience developing and launching brands and products in a wide variety of industries. Vestagen is backed by investors Advent Life Sciences, Alliance Healthcare Partners Group, founding investor V-Ten Capital and other private investors.